Melatonin in Patients With Multiple Sclerosis (MS).

NCT03498131 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG: 3 mg Melatonin
DRUG: 5 mg Melatonin

Sponsor

Providence Health & Services